Driving Cancer Through ErbB3

Science-Business eXchange
doi 10.1038/scibx.2013.535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis

Cancer Research
Cancer ResearchOncology
2006English

Targeting of erbB3 Receptor to Overcome Resistance in Cancer Treatment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics

Oncotarget
Oncology
2012English

Targeting ErbB3: The New RTK(id) on the Prostate Cancer Block

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry
ImmunologyPharmacologyEndocrinologyAllergyMetabolismDiabetes
2011English

Driving Internationalization Through Business Model Innovation

Multinational Business Review
AccountingManagementInternational ManagementBusiness
2019English

Pin1 Inhibition Exerts Potent Activity Against Acute Myeloid Leukemia Through Blocking Multiple Cancer-Driving Pathways

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Glioblastoma Stem Cells: Driving Resilience Through Chaos

Trends in Cancer
Cancer ResearchOncology
2020English

“The Driving Analysis System Through Wireless Network”

IOSR Journal of Computer Engineering
2013English

The ER Structural Protein Rtn4A Stabilizes and Enhances Signaling Through the Receptor Tyrosine Kinase ErbB3

Science Signaling
BiochemistryCell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy